About Stevanato Group SpA 
Stevanato Group SpA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 48 Schemes (51.57%)
Foreign Institutions
Held by 68 Foreign Institutions (18.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
318 Million
(Quarterly Results - Jun 2025)
Net Profit:
34 Million
Pharmaceuticals & Biotechnology
USD 964 Million (Small Cap)
47.00
NA
0.00%
0.23
8.77%
0.57






